BLUEROCK HOMES TRUST INC (BHM)

US09631H1005 - Common Stock

14.79  -0.21 (-1.4%)

Fundamental Rating

2

Overall BHM gets a fundamental rating of 2 out of 10. We evaluated BHM against 20 industry peers in the Residential REITs industry. Both the profitability and financial health of BHM have multiple concerns. BHM is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

In the past year BHM has reported negative net income.
In the past year BHM had a positive cash flow from operations.

1.2 Ratios

BHM has a worse Return On Assets (-0.70%) than 70.00% of its industry peers.
BHM's Return On Equity of -2.77% is on the low side compared to the rest of the industry. BHM is outperformed by 65.00% of its industry peers.
Industry RankSector Rank
ROA -0.7%
ROE -2.77%
ROIC N/A
ROA(3y)5.89%
ROA(5y)N/A
ROE(3y)6.41%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

BHM has a worse Gross Margin (42.57%) than 95.00% of its industry peers.
In the last couple of years the Gross Margin of BHM has declined.
BHM does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.57%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.12%
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

BHM does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BHM has more shares outstanding
Compared to 1 year ago, BHM has a worse debt to assets ratio.

2.2 Solvency

BHM has an Altman-Z score of 0.27. This is a bad value and indicates that BHM is not financially healthy and even has some risk of bankruptcy.
BHM has a Altman-Z score of 0.27. This is amonst the worse of the industry: BHM underperforms 85.00% of its industry peers.
BHM has a Debt/Equity ratio of 1.07. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.07, BHM is in line with its industry, outperforming 55.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF N/A
Altman-Z 0.27
ROIC/WACCN/A
WACC5.73%

2.3 Liquidity

BHM has a Current Ratio of 4.02. This indicates that BHM is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of BHM (4.02) is better than 100.00% of its industry peers.
BHM has a Quick Ratio of 4.02. This indicates that BHM is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 4.02, BHM belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.02
Quick Ratio 4.02

3

3. Growth

3.1 Past

BHM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -149.84%.
Looking at the last year, BHM shows a quite strong growth in Revenue. The Revenue has grown by 14.35% in the last year.
The Revenue has been growing by 77.33% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-149.84%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-370.73%
Revenue 1Y (TTM)14.35%
Revenue growth 3Y77.33%
Revenue growth 5YN/A
Sales Q2Q%21.94%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

BHM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

95.00% of the companies in the same industry are cheaper than BHM, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 46.78

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

BHM has a Yearly Dividend Yield of 6.76%, which is a nice return.
Compared to an average industry Dividend Yield of 3.84, BHM pays a better dividend. On top of this BHM pays more dividend than 95.00% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.26, BHM pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.76%

5.2 History

BHM does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of BHM are negative and hence is the payout ratio. BHM will probably not be able to sustain this dividend level.
DP-86.31%
EPS Next 2YN/A
EPS Next 3YN/A

BLUEROCK HOMES TRUST INC

NYSEARCA:BHM (9/6/2024, 8:04:02 PM)

14.79

-0.21 (-1.4%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryResidential REITs
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap58.42M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 6.76%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.7%
ROE -2.77%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 42.57%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 1.07
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 4.02
Quick Ratio 4.02
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-149.84%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)14.35%
Revenue growth 3Y77.33%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y